The Brigham’s 7T MRI unit, just the second in the country to be approved for clinical use, revealed that a potential biomarker of brain inflammation in patients affected by multiple sclerosis is more common than previously thought.
The 16-hour surgery, involving a team of over 45 surgeons, nurses, anesthesiologists, residents and research fellows, and led by Bohdan Pomahac, MD, was the ninth face transplant procedure at the Brigham and the 15th nationwide.
New research from Brigham and Women's Hospital researchers reveals that both step and time-based exercise targets are equivalently associated with improved health outcomes, extended lifespan, and reduced risk of cardiovascular disease Read More...
Using real world clinical data, Brigham researchers found that 82 percent of patients had one year free from atrial fibrillation after an ablation procedure with procedural complications under 2 percent Read More...
The Testing for Identification of Markers of Stroke (TIME) trial demonstrates the accuracy of a new blood test that can quickly and accurately identify an aggressive type of stroke with the potential to bring life-saving care to patients globally Read More...
